Allan E. Rettie
Department of Medicinal Chemistry
School of Pharmacy
University of Washington
Box 357610
Name/email consistency: high
- CYP4V2 in Bietti's Crystalline Dystrophy: Ocular Localization, Metabolism of ω-3-Polyunsaturated Fatty Acids, and Functional Deficit of the p.H331P Variant. Nakano, M., Kelly, E.J., Wiek, C., Hanenberg, H., Rettie, A.E. Mol. Pharmacol. (2012)
- A case study of acenocoumarol sensitivity and genotype-phenotype discordancy explained by combinations of polymorphisms in VKORC1 and CYP2C9. Rettie, A.E., Farin, F.M., Beri, N.G., Srinouanprachanh, S.L., Rieder, M.J., Thijssen, H.H. Br. J. Clin. Pharmacol (2006)
- The pharmocogenomics of warfarin: closing in on personalized medicine. Rettie, A.E., Tai, G. Mol. Interv. (2006)
- Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics. Rettie, A.E., Jones, J.P. Annu. Rev. Pharmacol. Toxicol. (2005)